SI-BONE To Report First Quarter 2022 Financial Results on May 9, 2022

SI-BONE, Inc. (Nasdaq: SIBN) will report its Q1 2022 financial results on May 9, 2022, after market close.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

SI-BONE, Inc. (Nasdaq: SIBN) will report its Q1 2022 financial results on May 9, 2022, after market close. A conference call will follow at 1:30 p.m. PT, with access for investors via phone or webcast. As a leader in surgical treatment for sacropelvic disorders, SI-BONE's iFuse Implant System has facilitated over 65,000 SI joint fusion procedures, supported by extensive clinical evidence and insurance coverage. The company continues to leverage its market position to develop additional surgical devices.

Positive

Market leader in sacropelvic disorder treatment.
Over 65,000 SI joint fusion procedures performed.
Strong clinical evidence supporting the iFuse Implant System.

Negative

None.

Argus Session date unavailable

-5.93% session move Open Argus

Details

News Market Reaction – SIBN

The recorded move for SIBN in the trading session of this news was -5.93%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

04/18/2022 - 08:00 AM EDT

SANTA CLARA, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the first quarter of 2022 after market close on Monday, May 9, 2022. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by dialing (866) 470-1968 for domestic callers or (409) 217-8248 for international callers, using conference ID: 6088498. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.

About SI-BONE, Inc.

SI-BONE (NASDAQ: SIBN) is a global leader in technology for surgical treatment of musculoskeletal disorders of the sacropelvic anatomy. In 2009, SI-BONE introduced the iFuse Implant System for minimally invasive surgery of the SI joint, shown to be a source of pain in 15% to 30% of chronic low back pain. Since then, more than 2,700 surgeons have performed a combined total of more than 65,000 SI joint fusion procedures. A unique body of evidence, supporting the iFuse Implant System, including two RCT’s and over 100 peer reviewed publications, has enabled multiple government and private insurance payors to establish coverage of the SI joint fusion procedure exclusively when performed with the iFuse Implant System. SI-BONE is leveraging its market leadership position, supported by this proprietary reimbursement advantage, to commercialize other devices intended for surgical treatment of related aspects of the human anatomy. For more information or to join our team, please visit us at www.si-bone.com.

For additional information on the company or the products including risks and benefits, please visit www.si-bone.com.

Investor Contact:
Matt Bacso, CFA
investors@SI-BONE.com

Media Contact:
Joe Powers
jpowers@si-bone.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will SI-BONE report its Q1 2022 financial results?

SI-BONE will report its Q1 2022 financial results on May 9, 2022, after market close.

What time is the SI-BONE conference call?

The conference call will begin at 1:30 p.m. Pacific Time on May 9, 2022.

How can I listen to the SI-BONE conference call?

Investors can listen to the conference call by dialing (866) 470-1968 for domestic callers or (409) 217-8248 for international callers, using conference ID: 6088498.

What is the significance of the iFuse Implant System?

The iFuse Implant System is a minimally invasive surgical device for SI joint fusion, with over 65,000 procedures performed and strong clinical support.

SI-BONE To Report First Quarter 2022 Financial Results on May 9, 2022